palmitic acid has been researched along with entinostat in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abderrahmani, A; Annicotte, JS; Gmyr, V; Kerr-Conte, J; Pattou, F; Plaisance, V; Rolland, L | 1 |
1 other study(ies) available for palmitic acid and entinostat
| Article | Year |
|---|---|
The class I histone deacetylase inhibitor MS-275 prevents pancreatic beta cell death induced by palmitate.
Topics: Activating Transcription Factor 3; Animals; Apoptosis; Benzamides; Cell Line, Tumor; Cytoprotection; Histone Deacetylase 1; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Insulin-Secreting Cells; Mice; Palmitic Acid; Pyridines; RNA Interference; Signal Transduction; Tissue Culture Techniques; Transcription Factor CHOP; Transfection | 2014 |